PrecisCa
PrecisCa supports patients, their caregivers, and health care providers at every step of their cancer journeys from diagnosis to remission, with up-to-date education on the latest advancements in cancer care and access to leading specialists to analyze patient scenarios
Video Player is loading.
Targeted Drugs for Patients With ROS1 Rearrangement With NSCLC: General Approach, Side Effects, New Drugs in the Pipeline
By
PrecisCa
FEATURING
Suresh Ramalingam
By
PrecisCa
FEATURING
Suresh Ramalingam
Comments 0
Login to view comments.
Click here to Login
